GENT — Gentian Diagnostics ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK567.54m
- NOK492.95m
- NOK135.15m
- 64
- 10
- 40
- 28
Annual cashflow statement for Gentian Diagnostics ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -39.9 | -17.5 | -24.8 | -23.6 | -10.6 |
| Depreciation | |||||
| Non-Cash Items | 16 | 3.28 | 4.63 | 3.35 | 8.62 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.71 | -4.95 | -14.2 | -3.93 | 7.92 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -21.5 | -12.5 | -27.1 | -14 | 15.5 |
| Capital Expenditures | -4.04 | -6.47 | -12.8 | -14.7 | -4.49 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 6.74 | 0 | 0 | -0.39 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.04 | 0.274 | -12.8 | -14.7 | -4.88 |
| Financing Cash Flow Items | 0.001 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.58 | -1.51 | -3.12 | -4.33 | -4.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -27.1 | -13.6 | -43 | -33.3 | 6.04 |